TMO - Thermo Fisher Scientific Inc.

NYSE - NYSE Delayed price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
44,915,000
44,915,000
39,211,000
32,218,000
25,542,000
Cost of revenue
25,944,000
25,415,000
18,977,000
15,713,000
13,715,000
Gross profit
18,971,000
19,500,000
20,234,000
16,505,000
11,827,000
Operating expenses
Research development
1,471,000
1,471,000
1,406,000
1,181,000
1,003,000
Selling general and administrative
8,993,000
7,127,000
6,842,000
5,764,000
4,930,000
Total operating expenses
10,464,000
10,993,000
10,009,000
8,612,000
7,646,000
Operating income or loss
8,507,000
8,507,000
10,225,000
7,893,000
4,181,000
Interest expense
726,000
726,000
536,000
553,000
676,000
Total other income/expenses net
-218,000
-218,000
-891,000
-180,000
341,000
Income before tax
7,835,000
7,835,000
8,841,000
7,225,000
4,070,000
Income tax expense
703,000
703,000
1,109,000
850,000
374,000
Income from continuing operations
6,960,000
6,960,000
7,728,000
6,375,000
3,696,000
Net income
6,950,000
6,950,000
7,725,000
6,375,000
3,696,000
Net income available to common shareholders
6,950,000
6,950,000
7,725,000
6,375,000
3,696,000
Basic EPS
-
17.75
19.62
16.09
9.24
Diluted EPS
-
17.63
19.46
15.96
9.17
Basic average shares
-
392,000
394,000
396,000
400,000
Diluted average shares
-
394,000
397,000
399,000
403,000
EBITDA
-
11,942,000
11,969,000
10,103,000
7,023,000